PbTII cells were transferred to C57BL/6 and NLRP3−/− mice 1 day prior to infection with either Δpm4Δbp2 or Δlap parasites. Splenic GC responses were evaluated on day 14 p.i.
(A) Representative flow plots of CD150loCXCR5int TFH and CXCR5hiPD-1hi GC-TFH populations.
(B) CXCR5hiPD-1hi GC-TFH cells were sort purified on day 14 p.i., co-cultured with naive B cells, and the frequency of CD95+GL-7+ GC B cells was quantified after 5 days.
(C and D) Representative flow plots (C) and frequency (D) of CD80+PD-L2+CD73+CD38+CD95neg MBC on day 28 p.i.
(E) C57BL/6 and NLRP3−/− mice were immunized with Δpm4Δbp2 and Δlap parasites 60 days prior to challenge with a virulent Pb-ANKA strain.
(F) Frequency of immune mice that survived virulent Pb-ANKA challenge.
(G) MSP11–19-specific IgG endpoint titers 1 day prior to (pre) and 5 days after (post) virulent Pb-ANKA challenge.
Data (mean ± SD) in (A)–(D) are representative of three experiments with n = 3–4. Data (mean ± SD) in (E)–(G) are representative of two independent experiments with n = 3–4 per experimental group (see also Figure S5).